Swedbank AB grew its stake in shares of IQVIA Holdings Inc. (NYSE:IQV – Free Report) by 0.9% throughout the third quarter, based on the corporate in its most up-to-date 13F submitting with the Securities & Trade Fee. The fund owned 91,489 shares of the medical analysis firm’s inventory after buying an extra 786 shares throughout the quarter. Swedbank AB owned about 0.05% of IQVIA value $21,680,000 as of its most up-to-date SEC submitting.
A lot of different giant traders have additionally lately made adjustments to their positions in IQV. Park Place Capital Corp bought a brand new stake in IQVIA within the third quarter value roughly $28,000. Rise Advisors LLC purchased a brand new stake in shares of IQVIA within the first quarter value $31,000. Versant Capital Administration Inc elevated its place in IQVIA by 733.3% throughout the second quarter. Versant Capital Administration Inc now owns 125 shares of the medical analysis firm’s inventory valued at $26,000 after buying an extra 110 shares over the last quarter. Riverview Belief Co purchased a brand new place in IQVIA within the first quarter valued at about $32,000. Lastly, Opal Wealth Advisors LLC bought a brand new place in IQVIA within the second quarter value about $27,000. 89.62% of the inventory is at present owned by institutional traders.
Insider Exercise at IQVIA
In different IQVIA information, insider Eric Sherbet bought 1,300 shares of the corporate’s inventory in a transaction that occurred on Tuesday, August twenty seventh. The inventory was bought at a mean value of $246.33, for a complete transaction of $320,229.00. Following the sale, the insider now instantly owns 19,536 shares within the firm, valued at $4,812,302.88. This represents a 0.00 % lower of their possession of the inventory. The sale was disclosed in a doc filed with the SEC, which is obtainable at this hyperlink. 1.60% of the inventory is owned by insiders.
Analysts Set New Worth Targets
A number of equities analysts have lately weighed in on IQV shares. Royal Financial institution of Canada initiated protection on shares of IQVIA in a analysis notice on Wednesday, September 4th. They issued an “outperform” score and a $275.00 value goal on the inventory. JPMorgan Chase & Co. lifted their value goal on shares of IQVIA from $260.00 to $288.00 and gave the inventory an “obese” score in a analysis notice on Monday, August fifth. Morgan Stanley upped their value goal on IQVIA from $270.00 to $280.00 and gave the inventory an “obese” score in a analysis notice on Tuesday, July twenty third. StockNews.com upgraded IQVIA from a “maintain” score to a “purchase” score in a analysis report on Monday. Lastly, UBS Group upped their value goal on IQVIA from $295.00 to $300.00 and gave the inventory a “purchase” score in a analysis report on Tuesday, July twenty third. 4 funding analysts have rated the inventory with a maintain score, 13 have issued a purchase score and one has issued a robust purchase score to the inventory. In line with knowledge from MarketBeat, the corporate presently has a mean score of “Reasonable Purchase” and a mean goal value of $267.87.
View Our Newest Inventory Evaluation on IQV
IQVIA Worth Efficiency
NYSE:IQV opened at $233.06 on Thursday. The enterprise’s 50-day shifting common is $239.14 and its 200 day shifting common is $231.33. IQVIA Holdings Inc. has a 12 month low of $167.42 and a 12 month excessive of $261.73. The corporate has a market capitalization of $42.46 billion, a P/E ratio of 31.84, a P/E/G ratio of two.18 and a beta of 1.49. The corporate has a present ratio of 0.85, a fast ratio of 0.85 and a debt-to-equity ratio of 1.80.
IQVIA (NYSE:IQV – Get Free Report) final posted its earnings outcomes on Monday, July twenty second. The medical analysis firm reported $2.64 earnings per share for the quarter, beating analysts’ consensus estimates of $2.57 by $0.07. IQVIA had a internet margin of 9.39% and a return on fairness of 28.59%. The agency had income of $3.81 billion throughout the quarter, in comparison with analyst estimates of $3.79 billion. Throughout the identical interval final yr, the agency posted $2.22 earnings per share. IQVIA’s income for the quarter was up 2.3% in comparison with the identical quarter final yr. On common, equities analysis analysts forecast that IQVIA Holdings Inc. will publish 10.25 earnings per share for the present fiscal yr.
IQVIA Profile
IQVIA Holdings Inc engages within the provision of superior analytics, know-how options, and medical analysis companies to the life sciences business within the Americas, Europe, Africa, and the Asia-Pacific. It operates by means of three segments: Know-how & Analytics Options, Analysis & Growth Options, and Contract Gross sales & Medical Options.
Featured Tales
Need to see what different hedge funds are holding IQV? Go to HoldingsChannel.com to get the most recent 13F filings and insider trades for IQVIA Holdings Inc. (NYSE:IQV – Free Report).
Obtain Information & Scores for IQVIA Each day – Enter your e-mail deal with under to obtain a concise every day abstract of the most recent information and analysts’ rankings for IQVIA and associated corporations with MarketBeat.com’s FREE every day e-mail e-newsletter.
